Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Bioventus Inc Cl A (BVS)

Bioventus Inc Cl A (BVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 501,121
  • Shares Outstanding, K 79,166
  • Annual Sales, $ 512,350 K
  • Annual Income, $ -156,230 K
  • 60-Month Beta 0.63
  • Price/Sales 0.97
  • Price/Cash Flow 7.88
  • Price/Book 2.27
Trade BVS with:

Options Overview Details

View History
  • Implied Volatility 72.59% ( -7.31%)
  • Historical Volatility 84.25%
  • IV Percentile 4%
  • IV Rank 23.19%
  • IV High 194.78% on 10/20/23
  • IV Low 35.70% on 05/21/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 146
  • Volume Avg (30-Day) 283
  • Put/Call OI Ratio 0.95
  • Today's Open Interest 4,353
  • Open Int (30-Day) 4,640

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 0.07
  • Number of Estimates 1
  • High Estimate 0.07
  • Low Estimate 0.07
  • Prior Year 0.14
  • Growth Rate Est. (year over year) -50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.90 +63.33%
on 04/30/24
6.80 -6.32%
on 05/17/24
+2.22 (+53.49%)
since 04/24/24
3-Month
3.90 +63.33%
on 04/30/24
6.80 -6.32%
on 05/17/24
+1.59 (+33.26%)
since 02/23/24
52-Week
2.47 +157.76%
on 05/25/23
6.80 -6.32%
on 05/17/24
+3.81 (+148.83%)
since 05/24/23

Most Recent Stories

More News
AcelRx Pharmaceuticals (ACRX) Reports Break-Even Earnings for Q1

AcelRx Pharmaceuticals (ACRX) delivered earnings and revenue surprises of 100% and 100%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

ACRX : 0.8600 (+7.50%)
BVS : 6.37 (+0.63%)
Durect (DRRX) Reports Q1 Loss, Misses Revenue Estimates

Durect (DRRX) delivered earnings and revenue surprises of -4% and 41.81%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

DRRX : 1.3000 (+3.17%)
BVS : 6.37 (+0.63%)
New Strong Sell Stocks for April 5th

BVS, BFAM and ESTE have been added to the Zacks Rank #5 (Strong Sell) List on April 5, 2023.

BFAM : 107.62 (-0.81%)
ESTE : 21.17 (+0.47%)
BVS : 6.37 (+0.63%)
Journey Medical Corporation (DERM) Reports Q4 Loss, Misses Revenue Estimates

Journey Medical Corporation (DERM) delivered earnings and revenue surprises of -62.16% and 4.20%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the...

DERM : 3.60 (unch)
BVS : 6.37 (+0.63%)
ProPhase Labs, Inc. (PRPH) Reports Q4 Loss, Tops Revenue Estimates

ProPhase Labs, Inc. (PRPH) delivered earnings and revenue surprises of -500% and 6.30%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

PRPH : 5.05 (-5.25%)
BVS : 6.37 (+0.63%)
Alpine Immune Sciences, Inc. (ALPN) Reports Q4 Loss, Lags Revenue Estimates

Alpine Immune Sciences, Inc. (ALPN) delivered earnings and revenue surprises of -51.85% and 73.36%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the...

ALPN : 64.97 (+0.02%)
BVS : 6.37 (+0.63%)
Are Options Traders Betting on a Big Move in Bioventus (BVS) Stock?

Investors need to pay close attention to Bioventus (BVS) stock based on the movements in the options market lately.

BVS : 6.37 (+0.63%)
4D Molecular Therapeutics, Inc. (FDMT) Reports Q4 Loss, Lags Revenue Estimates

4D Molecular Therapeutics, Inc. (FDMT) delivered earnings and revenue surprises of -12% and 74.90%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the...

FDMT : 25.15 (unch)
BVS : 6.37 (+0.63%)
SHAREHOLDER ALERT FILING DEADLINE TODAY: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Bioventus Inc. of Class Action Lawsuit and Upcoming Deadline - BVS

/PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Bioventus Inc. ("Bioventus" or the "Company") (NASDAQ: BVS) and...

BVS : 6.37 (+0.63%)
Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Bioventus Inc. (BVS) Investors of Class Action and Last Few Hours to Actively Participate

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Bioventus Inc. (“Bioventus” or the “Company”) (NASDAQ: BVS) and certain...

BVS : 6.37 (+0.63%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Bioventus Inc. delivers clinically proven, cost-effective products which help people heal quickly and safely. It includes offerings for osteoarthritis, surgical and non-surgical bone healing. Bioventus Inc. is based in DURHAM, N.C.

See More

Key Turning Points

3rd Resistance Point 6.57
2nd Resistance Point 6.49
1st Resistance Point 6.43
Last Price 6.37
1st Support Level 6.28
2nd Support Level 6.20
3rd Support Level 6.14

See More

52-Week High 6.80
Last Price 6.37
Fibonacci 61.8% 5.15
Fibonacci 50% 4.64
Fibonacci 38.2% 4.12
52-Week Low 2.47

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar